Research in child and adolescent psychopharmacology: recent accomplishments and new challenges
- 609 Downloads
Research in pediatric psychopharmacology has expanded considerably in the last 10 years. Still, controversy remains about the effectiveness and safety of commonly used psychotropics and their role in child treatment, thus pointing to the need for more in-depth and targeted investigations.
To review recent accomplishments and current limitations of pediatric psychopharmacology, and discuss approaches to further research.
Selective review of the relevant literature and research in progress.
Controlled clinical trials have been conducted in many common psychiatric disorders in children and adolescents, thus providing a basis on which evidence-based treatment guidelines can be constructed. Little innovation has, however, occurred in treatment development and testing. Safety concerns are prominent and have a major influence on clinical practice and drug utilization.
While a research infrastructure has been successfully built for conducting pediatric clinical trials, important aspects such as long-term treatment effects, optimal sequencing and individualization of interventions, and integration of neuroscience findings into innovative, theory-driven treatment development remain to be addressed.
KeywordsPsychopharmacology Children Adolescents Research
The opinions and assertions contained in this chapter are the private views of the author and are not to be construed as official or as reflecting the views of the National Institute of Mental Health, the National Institutes of Health, or the Department of Health and Human Services.
- American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DCGoogle Scholar
- Angold A, Erkanli A, Egger HL, Costello EJ (2002) Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry 39:975–984Google Scholar
- Bradley C (1937) The behavior of children receiving Benzedrine. Am J Psychiatry 94:577–585Google Scholar
- Curry JF, Rohde R, Simons A, Silva SG, Vitiello B, Kratochvil CJ, March JS, Reinecke MA, Feeny N, Wells KC, Pathak S, Weller E, Rosenberg D, Kennard BD, Robins M, Ginsburg GS, TADS Team (2006) Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry (in press)Google Scholar
- DeVeaugh-Geiss J, March J, Andreason P, Clary C, Emslie G, Ford L, Greenhill L, Murphy D, Prentice E, Roberts R, Silva S, Swanson S, van Zwieten-Boot B, Vitiello B, Wagner KD, Shapiro M, Mangum B (2006) A workshop on child and adolescent psychopharmacology in the new millennium. J Am Acad Child Adolesc Psychiatry 45:261–270CrossRefPubMedGoogle Scholar
- Emslie GJ, Heiligenstein JH, Hoog SL, Wagner KD, Findling RL, McCracken JT, Nilsson ME, Jacobson JG (2004) Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 43:1397–1405CrossRefPubMedGoogle Scholar
- Food and Drug Administration (2005) FDA Alert: Adderall and Adderall XR (amphetamines)—Information (February 10, 2005). Available at Website: http://www.fda.gov/cder/drug/infopage/adderall/default.htm
- Food and Drug Administration (2006) Approved moieties to which FDA has issued a written request for pediatric studies under section 505A of the Federal Food, Drug, and Cosmetic Act. Available at: http://www.fda.gov/cder/pediatric/wrstats.htm (Last updated February 28, 2006; accessibility verified March 31, 2006)
- Geller DA, Wagner KD, Emslie G, Murphy T, Carpenter D, Wetherhold E, Perera P, Machin A, Gardiner C (2004) Paroxetine treatment in children and adolescents with obsessive–compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 43:1387–1396CrossRefPubMedGoogle Scholar
- Greenhill LL, Pliszka S, Dulcan M, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S, American Academy of Child and Adolescent Psychiatry (2002) Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 41(2 Suppl):26S–49SPubMedGoogle Scholar
- Greenhill LL, Vitiello B, Riddle MA, Fisher P, Shockey E, March JS, Levine J, Fried J, Abikoff H, Zito JM, McCracken JT, Findling RL, Robinson J, Cooper TB, Davies M, Varipatis E, Labellarte MJ, Scahill L, Walkup JT, Capasso L, Rosengarten J (2003) Review of safety assessment methods used in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry 42:627–633CrossRefPubMedGoogle Scholar
- Greenhill LL, Vitiello B, Fisher P, Levine J, Davies M, Abikoff HB, Chuang S, Findling RL, March JS, Scahill L, Walkup J, Riddle MA (2004) Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry 43:1488–1496CrossRefPubMedGoogle Scholar
- Greenhill LL, Abikoff H, Chuang S, Cooper T, Cunningham C, Davies M, Ghuman J, Kollins S, McCracken JT, McGough J, Posner K, Riddle MA, Skrobala A, Swanson A, Vitiello B, Wigal S, Wigal T (2006) Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry (in press)Google Scholar
- Hazell P, O'Connell D, Heathcote D, Henry D (2002) Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev 2:CD002317Google Scholar
- Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, Hinshaw S, Vitiello B, Arnold LE, Elliott G, Hechtman L, Newcorn JH, Pelham WE, Swanson J, Wells K (2005) Cost-effectiveness of ADHD treatments: findings from the Multimodal Treatment Study of Children with ADHD. Am J Psychiatry 162:1628–1636CrossRefPubMedGoogle Scholar
- Kollins SH, Greenhill LL, Swanson S, Wigal S, Abikoff H, McCracken JT, Riddle M, McGough JJ, Vitiello B, Wigal T, Skrobala AM, Posner K, Ghuman JK, Davies M, Cunningham C, Bauzo A (2006) Rationale, Design, and Methods of the Preschool ADHD Treatment Study (PATS). J Am Acad Child Adolesc Psychiatry (in press)Google Scholar
- Martin A, Scahill L, Charney D, Leckman JF (2003) Child and Adolescent Psychopharmacology. Oxford University Press, New York, NYGoogle Scholar
- National Institute of Mental Health (2001) Blueprint for Change: Research on Child and Adolescent Mental Health. Report of the National Advisory Mental Health Council’s Workgroup on Child and Adolescent Mental Health Intervention Development and Deployment. Washington, DC (Available at Web site: http://www.nimh.nih.gov/publicat/nimhblueprint.pdf; access verified on March 31, 2006)
- National Institute of Mental Health (2005) Treatment Research in Mental Illness: Improving the Nation’s Public Mental Health Care through NIMH Funded Interventions Research. Report of the National Advisory Mental Health Council’s Workgroup on Clinical Trials. (Available at Web site: http://www.nimh.nih.gov/council/interventions_research.pdf; access verified on March 31, 2006)
- Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ; COMACS Study Group (2004) A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the COMACS study). Pediatrics 113(3 Pt 1):e206–e216CrossRefPubMedGoogle Scholar
- Tourette’s Syndrome Study Group (2002) Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 58:527–536Google Scholar
- US Congress (1997) Food and Drug Administration Modernization Act. Public Law 105–115Google Scholar
- US Congress (2002) Best Pharmaceuticals for Children Act (BPCA). Public Law 107–109Google Scholar
- US Congress (2003) Pediatric Research Equity Act of 2003. Public Law 108–155Google Scholar
- US Public Health Service (2000) Report of the surgeon general’s conference on children’s mental health: a national action agenda. Washington, DCGoogle Scholar
- Vitiello B, Riddle MA, Greenhill LL, March JS, Levine J, Schachar R, Abikoff H, Zito J, McCracken J, Walkup J, Findling RL, Robinson J, Cooper T, Davies M, Varipatis E, Labellarte M, Scahill L, Capasso L (2003) How can we improve the assessment of safety in child and adolescent psychopharmacology? J Am Acad Child Adolesc Psychiatry 42:634–641CrossRefPubMedGoogle Scholar
- Werry JS, Aman MG (1999) Practitioner’s guide to psychoactive drugs for children and adolescents. Plenum Publishing, New York, NYGoogle Scholar